Are gut microbiome tests actually accurate?

Are gut microbiome tests accurate?

Partly. Gut microbiome tests are technically real but clinically unvalidated. Laboratories can genuinely sequence the bacterial DNA in your sample — but when researchers sent identical stool material to seven direct-to-consumer companies, the results differed between providers on a similar scale to the biological difference between two separate people (Communications Biology, 2026). No gut microbiome test can currently diagnose a condition, and none is approved as a diagnostic device. What a good test can do is describe the diversity and broad composition of your sample on the day you took it (you may like to read our blog about what the microbiome actually is), and give a qualified practitioner a structured starting point. This is exactly how we have always positioned our Ultimate Gut Health Test – a piece of the puzzle that allows an experienced nutritional therapist to provide evidence based health recommendations.

Key takeaways

• Reproducibility between companies is poor. Identical samples sent to seven providers produced major discrepancies both within and between them (Communications Biology, 2026).
• Your microbiome moves daily. For 78% of bacterial genera, day-to-day variation within one person exceeds variation between different people (Nature Communications, 2021).
• Microbiome tests cannot diagnose. An international consensus panel found evidence for clinical usefulness scarce and discouraged testing without a clinical reason (The Lancet Gastroenterology & Hepatology, 2025).
• No microbiome test is FDA- or MHRA-approved as a diagnostic device. These are wellness products, not medical tests.
• Consistency is what makes a result useful. Same laboratory, same method, same sequencing type — that is the only way a repeat test tells you anything about change over time.
• Reports are percentages, not headcounts. A ratio built from percentages inherits every one of their limitations.

What does “accurate” mean for a stool test?

Accuracy is three separate questions, and consumer microbiome tests score very differently on each.

A test can score well on analytical validity and still score poorly on clinical utility. Most of the debate about microbiome testing sits in that gap — and most marketing quietly conflates the three.

Related terms you may see: reproducibility (same result on repeat measurement), test–retest reliability, sensitivity and specificity (how well a test catches a condition and rules it out). Consumer microbiome reports generally do not publish sensitivity or specificity figures, because they are not making diagnostic claims.

Why do two labs give different results for the same sample?

Four decisions differ between laboratories, and each one changes your report:

1. Sample transit and preservation. Your bacteria are alive when they leave you. Temperature, time in the post and the preservative in the tube all shape which organisms survive to be counted.
2. DNA extraction — the largest single source of variation. Bacteria keep their DNA behind a cell wall, and the lab must break that wall. A gentle method leaves tough-walled bacteria unopened, so they barely appear in your report. A forceful method opens them but destroys delicate ones. The Microbiome Quality Control (MBQC) project sent identical, blinded samples to 15 laboratories and found extraction and handling among the largest sources of variation (Nature Biotechnology, 2017). A later review in Genome Biology described the absence of one agreed method as a real barrier to comparing studies.
3. Sequencing depth: 16S or shotgun. These read different amounts of DNA and produce different levels of detail (compared in the table below).
4. Reference database and detection thresholds. A computer matches each DNA fragment against a list of known bacteria. Labs use different lists, different rules for how close a match must be, and different cut-offs for how much of an organism must be present before it appears at all. The same bacterium can be given a different name by two labs, or listed by one and omitted by the other.

None of these choices is wrong. They are just different — which is precisely the problem when you try to compare one company’s report against another’s.

A useful way to picture it

Imagine counting everyone at a music festival. You cannot line up 50,000 people, so you sample the crowd and scale up. Send two survey teams on the same afternoon and they return different numbers. Neither is careless; they made different choices about where to stand, who to approach and who counts as “attending.” Those choices compound. A microbiome test faces exactly this problem with the bacteria in your sample.

What happened when identical samples were sent to seven companies?

Researchers prepared a standardised human faecal reference material and sent samples from that single, uniform source to seven direct-to-consumer microbiome testing services. Because every sample was identical, the results should have matched. They did not. Writing in Communications Biology  in 2026, the team reported major discrepancies both within and between providers — and the variation between companies was on a similar scale to the biological variation expected between two different people.

Two laboratories analysing your stool could therefore produce reports that differ as much as reports from two unrelated individuals.

The authors attributed this to methodological differences and a lack of quality control, rather than to any single company doing something wrong. A 2025 review in the Journal of Law, Medicine & Ethics raised parallel concerns about consumer protection and how results are presented to buyers.

Should you choose a 16S or a shotgun test?

What matters more than the choice itself is knowing which one you bought and staying with it. A 16S result and a shotgun result are not comparable, even from the same laboratory on the same sample.

Why do microbiome reports show percentages instead of counts?

Almost every report gives you percentages — the share of the crowd each bacterium makes up — rather than how big the crowd is. This trips up most readers, and it has a specific consequence.

Percentages always total 100, so they can only describe shares. If one group doubles in size, every other group’s share must fall, even though nothing about those groups has changed. Your report would show them dropping. In reality they stayed exactly the same.

This is not theoretical. Vandeputte and colleagues counted the actual number of bacterial cells alongside the sequencing and reported in Nature in 2017 that total microbial load varies widely between people — and that an apparent trade-off between two common bacterial groups turned out to be an artefact of working in percentages.

Practical implication: treat any reported ratio with caution, including the widely marketed Firmicutes-to-Bacteroidetes ratio. A ratio built from percentages carries every limitation of those percentages, and the F/B ratio in particular has not held up as a reliable marker of health status. The same caution applies to composite “gut health scores” and “dysbiosis indexes”: these are proprietary calculations, they are not standardised between companies, and a score from one provider means nothing in relation to a score from another.

How much does your microbiome change from day to day?

Substantially — often more than it differs between people. Researchers followed 20 healthy women, analysing a stool sample every day for six weeks (713 samples in total). Their 2021 paper in Nature Communications found that for 78% of bacterial genera, day-to-day variation within one person was larger than the variation between different people. Some organisms shifted up to 100-fold across the study.

Stool consistency was one of the main drivers. That fits earlier work in the scientific Journal Gut (2016), which found stool consistency — a proxy for gut transit time — correlates strongly with microbial richness, composition and community type.

What this means for your report: a single stool sample is a snapshot taken on one particular day, under one particular set of conditions. It is not a fixed portrait of your gut. The authors of the six-week study suggested repeated sampling, or a focus on broader community-level measures rather than individual species, would give more dependable information.

Can a gut microbiome test diagnose IBS, IBD or coeliac disease?

No. A gut microbiome test cannot diagnose IBS, coeliac disease, inflammatory bowel disease or any other condition, and no microbiome test is approved as a diagnostic device. An altered microbiome often signals that something is going on. It rarely tells you what.

The evidence here is unusually clear:

• A 2017 meta-analysis in Nature Communications pooled 28 case-control studies across ten conditions. About half of the bacterial genera linked to any one condition were also linked to several others. Duvallet and colleagues concluded that many associations are not disease-specific but part of a shared, non-specific response.
• A 2022 analysis in Genome Medicine reached a similar conclusion, describing a general microbial response detectable across a wide array of conditions.
• In 2025, an international panel of microbiome scientists and clinicians reviewed the field for The Lancet Gastroenterology & Hepatology. They concluded that evidence supporting the clinical usefulness of microbiome testing is scarce, and discouraged patients from requesting testing without a clinical reason.
• A 2025 review in Frontiers in Microbiology called for standardised protocols and stricter quality control before these tests are used diagnostically.

Please see your GP if you have red flag symptoms: bleeding, unexplained weight loss, persistent vomiting, or a change in bowel habit lasting more than a few weeks. These need proper medical assessment, not a stool sequencing report.

What tests are validated for gut symptoms?

If you want a diagnostic answer, these are the tests with established clinical validity — all available through your GP:

• Faecal calprotectin — distinguishes inflammatory bowel disease from IBS
• FIT (faecal immunochemical test) — screens for blood indicating possible bowel cancer
• Coeliac serology (tTG-IgA) — first-line screening for coeliac disease
• Breath testing — for lactose or fructose malabsorption, and used in SIBO assessment

A microbiome test is not a substitute for, or a shortcut past, any of these.

What can these tests reliably tell you?

Quite a lot — provided the claims stay proportionate.

Microbiome sequencing is a genuinely powerful research tool. A 2019 meta-analysis in Nature Medicine pooled shotgun data from eight colorectal cancer studies and identified a core set of 29 species that held up across geographically and technically diverse cohorts. Signatures trained on several studies retained accuracy in new populations. That is what real, replicable signal looks like.

Microbiome science has produced approved treatments. Faecal microbiota-based therapies for recurrent C. difficile infection are recommended in the American Gastroenterological Association’s 2024 clinical guideline — though the same guidance is clear that these therapies should only be considered within clinical trials for IBS and inflammatory bowel disease.

And a well-run consumer test, sensibly interpreted, can:

• Describe the overall diversity of your sample
• Show which broad functional groups appear well represented, such as fibre fermenters or organisms associated with butyrate production
• Flag potential pathogens worth discussing with a clinician
• Indicate the direction of change over time — but only when the same sample type is processed by the same laboratory using the same method

Consistency is the key requirement. Comparing a test from one company against a test from another is where reliability falls apart.

What should you look for in a gut microbiome test?

Five questions separate a thoughtful provider from a slick one:

• Is the method stated clearly? You should be able to find out whether it uses 16S or shotgun sequencing, and which laboratory processes the sample.
• Is the laboratory accredited? Ask for CLIA/CAP certification or UKAS accreditation to ISO 15189. A provider that cannot tell you where your sample goes is a provider to avoid.
• Will a repeat test use the same method? If not, the two results are not comparable and any “change over time” narrative is meaningless.
• Does someone qualified interpret the result? A report read alongside your history and symptoms is worth far more than a report read alone. Ask who that person is and where they are registered.
• Are the claims proportionate? Be wary of any report that names a single bacterium as the cause of your symptoms, promises a definitive answer, or produces a proprietary score without explaining how it is calculated.
• Is the recommended action reasonable on its own terms? Advice to eat a wider range of plants is sensible whatever your report says. A long and expensive supplement list based on one snapshot is a different matter.

How should you use your microbiome test results?

Treat a microbiome report as one piece of information among several — a contribution to a bigger picture, not the answer.

That picture includes your symptom history, your diet, your sleep, your stress load, your medication and antibiotic history, and any conventional investigations your GP has arranged. A number on a page means very little on its own. What it means depends on who you are and what else is going on.

Testing works best when it opens a conversation rather than closes one. Your microbiome will keep changing, because it responds to what you eat, how you sleep and how you live. That responsiveness is frustrating if you want a fixed number. It is encouraging if you want somewhere to start.

How Healthpath handles interpretation

Every Healthpath test is reviewed by a person rather than an algorithm. Our in-house, UK-based practitioners are Registered Nutritional Therapists and Functional Medicine practitioners, registered with bodies including BANT and the ANP. [[ADD SPECIFICS: number of practitioners, average years in practice, number of reports reviewed to date — this is the section with the weakest evidence density on the page.]]

They read your lab results alongside your completed symptom survey and health history, then write a plain-English summary of what the findings do and do not suggest. That review and written summary come with every test we sell.

Plan and Package options add a personalised 12-week plan covering food, supplements and lifestyle, plus a personal video in which your practitioner talks you through your results. The Package option adds a 30-minute one-to-one call with an experienced Nutritional Therapist. If we think your situation calls for more support than we can offer, we will refer you into our network of practitioners at no cost.

Testing can be helpful in understanding the reasons behind your symptoms, but results are only one part of the picture, and we do not recommend using them in isolation. Our products are not intended to diagnose, treat or prevent any disease.

Common questions about gut microbiome testing

Are gut microbiome tests accurate?

Partly. Laboratories can reliably sequence bacterial DNA, but identical samples sent to seven direct-to-consumer companies produced results differing on a similar scale to samples from two different people (Communications Biology, 2026). Tests are analytically variable between providers and clinically unvalidated. They can describe your sample’s diversity on a given day; they cannot diagnose.

Can a gut microbiome test diagnose IBS or IBD?

No. No microbiome test is approved as a diagnostic device for any condition. A 2017 meta-analysis across ten conditions found roughly half the bacterial genera linked to one condition were also linked to several others — the signal is real but non-specific. Faecal calprotectin, FIT and coeliac serology are the validated tests, available through your GP.

Why do two microbiome tests give different results?

Four laboratory decisions differ between providers: how the sample is preserved in transit, how bacterial cell walls are broken open to release DNA, whether the lab reads one short DNA region (16S) or all of it (shotgun), and which reference database and detection thresholds it applies. DNA extraction is the largest single source of variation (MBQC, Nature Biotechnology, 2017).

Are gut microbiome tests FDA-approved or MHRA-regulated?

No gut microbiome test is FDA-approved as a diagnostic device, and in the UK these tests are not regulated by the MHRA as diagnostic devices when sold for general wellness purposes. A 2025 review in the Journal of Law, Medicine & Ethics questioned whether current regulation adequately protects consumers.

Is a gut microbiome test worth the money?

That depends on what you expect. If you want a definitive answer to why you feel unwell, no stool test can give you that today. If you want a structured starting point, a picture of your microbial diversity, and a practitioner’s read on it alongside your symptoms, it can earn its place. Be wary of anyone who answers this question with an unqualified yes.

Should I choose a 16S or a shotgun test?

Shotgun sequencing reads all the DNA in the sample, identifies bacteria more precisely, and indicates what those organisms can do. It costs more. A 16S test reads one short DNA region and gives a broad picture of community composition at genus level. What matters most is knowing which you bought and staying with it if you plan to retest — the two are not comparable.

How should I prepare before taking my stool sample?

Follow your kit instructions closely, as they are written for that specific test. Take your sample on a typical day rather than during a stomach upset or a period of unusual eating: stool consistency and gut transit time strongly influence results (Gut, 2016). If you have recently taken antibiotics, note it on your symptom survey, as this changes how the report should be read. Contact us before posting if anything is unclear.

How often should I retest my microbiome?

Less often than most people expect. Because bacterial levels swing considerably from one day to the next — for 78% of genera, day-to-day variation exceeds between-person variation (Nature Communications, 2021) — a repeat test a few weeks later will mostly capture natural movement rather than real change. Retesting makes more sense after a sustained period of doing something differently, and when there is a specific question to answer.

Will my GP use my microbiome test results?

Usually not. A microbiome report is not a diagnostic test, so it cannot confirm or rule out a medical condition, and GPs work from validated diagnostic pathways. What the report can do is inform the food and lifestyle conversation you have with a practitioner. If you have symptoms needing medical investigation, the two run alongside each other rather than replacing one another.

References

1. Servetas et al., (2026) Evaluating the analytical performance of direct-to-consumer gut microbiome testing services. Communications Biology, 2026. PMC12946161.
2. Hoffman et al., (2025) Is the current regulatory framework for direct-to-consumer microbiome-based tests sufficient to protect consumers from medical, economic, and dignitary harms? Journal of Law, Medicine & Ethics, 2025. PMC12728816.
3. Sinha R, et al. Assessment of variation in microbial community amplicon sequencing by the Microbiome Quality Control (MBQC) project consortium. Nature Biotechnology, 2017;35(11):1077–1086. PMID 28967885
4. Greathouse KL, Sinha R, Vogtmann E. DNA extraction for human microbiome studies: the issue of standardization. Genome Biology, 2019;20:212. PMID 31639026
5. Vandeputte D, et al. Quantitative microbiome profiling links gut community variation to microbial load. Nature, 2017;551(7681):507–511. PMID 29143816
6. Vandeputte D, et al. Temporal variability in quantitative human gut microbiome profiles and implications for clinical research. Nature Communications, 2021;12:6740. PMC8602282
7. Vandeputte D, et al. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut, 2016;65(1):57–62. PMID 26069274
8. Duvallet C, et al. Meta-analysis of gut microbiome studies identifies disease-specific and shared responses. Nature Communications, 2017;8:1784. PMID 29209090
9. Abbas-Egbariya H, et al. Meta-analysis defines predominant shared microbial responses in various diseases and a specific inflammatory bowel disease signal. Genome Medicine, 2022. PMID 35197084
10. Porcari S, et al. International consensus statement on microbiome testing in clinical practice. The Lancet Gastroenterology & Hepatology, 2025;10(2):154–167. PMID 39647502
11. Navigating microbiome variability: implications for research, diagnostics, and direct-to-consumer testing. Frontiers in Microbiology, 2025. PMC12018463. [[Add first author.]]
12. Wirbel J, et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nature Medicine, 2019;25(4):679–689. PMID 30936547
13. Peery AF, et al. AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases. Gastroenterology, 2024;166(3):409–434. PMID 38395525

This article is for information only and is not medical advice. If you have persistent or worrying digestive symptoms, please speak to your GP or a qualified healthcare professional.